Data / Form D filings / Theron Pharmaceuticals, Inc.
Theron Pharmaceuticals, Inc.: Form D filings
Theron Pharmaceuticals, Inc., a pharmaceuticals company in Sunnyvale, CA, filed 4 Form D notices with the SEC between 2009 and 2015. The latest, on August 6, 2015, reports $409,099 sold of a $750,000 offering to 5 investors.
Find out what Theron Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 365 SAN ALESO AVENUE, Sunnyvale, CA, 94085
- Phone
- (408) 792-7424
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1458056
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 6, 2015 | New notice | $750,000 | $409,099 | $340,901 | 5 | Jul 24, 2015 | sec.gov |
| May 19, 2011 | New notice | $1,000,000 | $662,550 | $337,450 | 5 | May 10, 2011 | sec.gov |
| May 14, 2010 | New notice | $2,000,000 | $957,670 | $1,042,330 | 5 | May 12, 2010 | sec.gov |
| May 11, 2009 | New notice | $600,000 | $180,000 | $420,000 | 5 | May 5, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Meenakshi Sundaram Venkatraman | Executive Officer | |
| James W. Larrick | Director | |
| Xiaoming R. Zhang | Executive Officer, Director | |
| Allan W. Kramer, M.D. | Director | |
| Jurg R. Pfister | Executive Officer, Director | |
| Cary W. Queen, Ph.D. | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Aug 3, 2015 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Theron Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.